substance p has been researched along with Liver Cirrhosis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, HS; Kim, S | 1 |
| Cui, R; Jia, X; Peng, L; Yan, M; Zhao, J | 1 |
| Agogo, GO; Guo, J; Peng, L; Yan, M | 1 |
| Alpini, G; Bernuzzi, F; Francis, H; Glaser, S; Glaser, T; Huang, Q; Invernizzi, P; Kennedy, L; Meng, F; Venter, J; Wan, Y; Wu, N; Zhou, T | 1 |
| Andrade, A; Fernández-Rodriguez, CM; Núñez, M; Penas, J; Prieto, J; Quiroga, J; Sangro, B; Zozoya, JM | 1 |
| Groszmann, RJ; Isales, CM; Rodríguez-Pérez, F | 1 |
| Chang, FY; Chu, CJ; Hou, MC; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH; Tsai, YT; Wang, SS | 1 |
| Fujimoto, M; Fukui, H; Ishii, Y; Kikuchi, E; Koizumi, M; Kojima, H; Matsumura, M; Okamoto, S; Takaya, A; Tsujii, T; Tsukamoto, N; Uemura, M | 1 |
| Chan, CC; Chang, FY; Chu, CJ; Hou, MC; Hwang, SJ; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH; Luo, JC | 1 |
| Chang, FY; Chu, CJ; Hwang, SJ; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH | 1 |
1 review(s) available for substance p and Liver Cirrhosis
| Article | Year |
|---|---|
Substance P and fibrotic diseases.
Topics: Animals; Corneal Diseases; Fibrosis; Heart Diseases; Humans; Inflammation; Joint Diseases; Kidney Diseases; Liver Cirrhosis; Primary Myelofibrosis; Substance P; Wound Healing | 2019 |
9 other study(ies) available for substance p and Liver Cirrhosis
| Article | Year |
|---|---|
Substance-P prevents the cholestatic liver injury by regulating inflammatory responses.
Topics: Animals; Apoptosis; Cholestasis; Common Bile Duct; Gene Expression Regulation; Humans; Inflammation; Interleukin-10; Ligation; Liver; Liver Cirrhosis; Matrix Metalloproteinase 9; Rats; Substance P; T-Lymphocytes, Regulatory; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2021 |
Substance P promotes hepatic stellate cell proliferation and activation via the TGF-β1/Smad-3 signaling pathway.
Topics: Actins; Animals; Apoptosis; Cell Proliferation; Collagen Type I; Dose-Response Relationship, Drug; Hepatic Stellate Cells; Humans; Lipid Droplets; Liver Cirrhosis; Neurokinin-1 Receptor Antagonists; Rats; Receptors, Neurokinin-1; Signal Transduction; Smad3 Protein; Substance P; Transforming Growth Factor beta1 | 2017 |
Substance P increases liver fibrosis by differential changes in senescence of cholangiocytes and hepatic stellate cells.
Topics: Aging; Animals; Apoptosis; Bile Ducts; Biomarkers; Biopsy, Needle; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Hepatic Stellate Cells; Humans; Immunohistochemistry; Liver Cirrhosis; Liver Function Tests; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Random Allocation; RNA, Messenger; Sensitivity and Specificity; Substance P | 2017 |
Plasma levels of substance P in liver cirrhosis: relationship to the activation of vasopressor systems and urinary sodium excretion.
Topics: Aldosterone; Female; Hemodynamics; Humans; Liver Cirrhosis; Male; Middle Aged; Natriuresis; Norepinephrine; Portal System; Renin; Stents; Substance P | 1995 |
Platelet cytosolic calcium, peripheral hemodynamics, and vasodilatory peptides in liver cirrhosis.
Topics: Adult; Aged; Blood Platelets; Blood Pressure; Calcium; Cytosol; Glucagon; Hemodynamics; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Muscle, Smooth, Vascular; Substance P; Vascular Resistance; Vasoactive Intestinal Peptide; Vasodilation | 1993 |
Plasma substance P levels in patients with liver cirrhosis: relationship to systemic and portal hemodynamics.
Topics: Female; Hemodynamics; Humans; Immunoenzyme Techniques; Liver Cirrhosis; Male; Middle Aged; Portal System; Substance P; Thermodilution | 1997 |
Increased plasma levels of substance P and disturbed water excretion in patients with liver cirrhosis.
Topics: Adult; Case-Control Studies; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Norepinephrine; Severity of Illness Index; Substance P; Vasopressins; Water | 1998 |
Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis.
Topics: Aged; Case-Control Studies; Estradiol; Female; Forearm; Humans; Liver Cirrhosis; Logistic Models; Male; Regional Blood Flow; Substance P; Telangiectasis; Testosterone; Vasodilator Agents | 1999 |
Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.
Topics: Aged; Cholelithiasis; Disease Progression; Eating; Estradiol; Female; Gallbladder; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates; Nitrites; Prevalence; Substance P; Testosterone; Ultrasonography | 2000 |